These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

65 related items for PubMed ID: 11967810

  • 1. Losartan inhibits in vitro platelet activation: comparison with candesartan and valsartan.
    Núñez A, Gómez J, Zalba LR, Montón M, Jiménez A, Velasco S, López-Blaya A, Uriarte AC, Casado S, López-Farré A.
    J Renin Angiotensin Aldosterone Syst; 2000 Jun; 1(2):175-9. PubMed ID: 11967810
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Angiotensin II AT(1) receptor antagonists and platelet activation.
    López-Farré A, Sánchez de Miguel L, Montón M, Jiménez A, Lopez-Bloya A, Gómez J, Núñez A, Rico L, Casado S.
    Nephrol Dial Transplant; 2001 Jun; 16 Suppl 1():45-9. PubMed ID: 11369820
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Novel angiotensin II AT(1) receptor antagonist irbesartan prevents thromboxane A(2)-induced vasoconstriction in canine coronary arteries and human platelet aggregation.
    Li P, Fukuhara M, Diz DI, Ferrario CM, Brosnihan KB.
    J Pharmacol Exp Ther; 2000 Jan; 292(1):238-46. PubMed ID: 10604953
    [Abstract] [Full Text] [Related]

  • 7. Effect of losartan on human platelet activation.
    Guerra-Cuesta JI, Montón M, Rodríguez-Feo JA, Jiménez AM, González-Fernández F, Rico LA, García R, Gómez J, Farré J, Casado S, López-Farré A.
    J Hypertens; 1999 Mar; 17(3):447-52. PubMed ID: 10100084
    [Abstract] [Full Text] [Related]

  • 8. Angiotensin receptor blocker losartan suppresses platelet activity by interfering with thromboxane signaling.
    Schwemmer M, Sommer O, Bassenge E.
    Cardiovasc Drugs Ther; 2001 Jul; 15(4):301-7. PubMed ID: 11800413
    [Abstract] [Full Text] [Related]

  • 9. [Effect of losartan on human platelet activation by thromboxane A2].
    Guerra JI, Montón M, Rodríguez-Feo JA, Farré J, Jiménez AM, Núñez A, Gómez J, Rico L, Marcos P, Castilla C, Sánchez De Miguel L, Casado S, López-Farré A.
    Rev Esp Cardiol; 2000 Apr; 53(4):525-30. PubMed ID: 10758030
    [Abstract] [Full Text] [Related]

  • 10. Differential effects of losartan and candesartan on vasoconstrictor responses in the rat.
    Nossaman BD, Baber SR, Nazim MM, Detrolio JD, Kadowitz PJ.
    Can J Physiol Pharmacol; 2007 Apr; 85(3-4):360-71. PubMed ID: 17612645
    [Abstract] [Full Text] [Related]

  • 11. Antiplatelet action of losartan involves TXA2 receptor antagonism but not TXA2 synthase inhibition.
    Chłopicki S, Koda M, Chabielska E, Buczko W, Gryglewski RJ.
    J Physiol Pharmacol; 2000 Dec; 51(4 Pt 1):715-22. PubMed ID: 11192944
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Studies on the antithrombotic action of AT1 receptor antagonists.
    Buczko W, Matys T, Pawlak R, Kucharewicz I, Chabielska E.
    Med Sci Monit; 2001 Dec; 7(4):600-5. PubMed ID: 11433183
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [Abstract] [Full Text] [Related]

  • 16. Internalization of constitutively active N111G MUTANT of AT1 receptor induced by angiotensin II-receptor antagonists candesartan, losartan, and telmisartan: comparison with valsartan.
    Bhuiyan MA, Hossain M, Nakamura T, Ozaki M, Nagatomo T.
    J Pharmacol Sci; 2010 Oct; 112(4):459-62. PubMed ID: 20308802
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Combined administration of 5-HT2 and thromboxane A2 antagonists: effects on platelet aggregation and isolated cardiac muscle.
    Shaw LA, Batey AJ, Coker SJ.
    Br J Pharmacol; 1997 Jul; 121(5):875-82. PubMed ID: 9222543
    [Abstract] [Full Text] [Related]

  • 20. Binding sites of valsartan, candesartan and losartan with angiotensin II receptor 1 subtype by molecular modeling.
    Bhuiyan MA, Ishiguro M, Hossain M, Nakamura T, Ozaki M, Miura S, Nagatomo T.
    Life Sci; 2009 Jul 17; 85(3-4):136-40. PubMed ID: 19446572
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.